44 results on '"Hodge, Alex"'
Search Results
2. COVID-19 vaccinations in patients with chronic liver disease – experience of a tertiary centre in Melbourne
3. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
4. Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells
5. Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells
6. Reply to Abenavoli et al. Comment on “Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687”
7. NAFLD prevalence in the elderly declines with age and is associated with increased frailty, reduced physical function and social disadvantage status: results from the ASPREE study
8. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
9. Antibody Validation by Western Blotting
10. Reverse Phase Protein Microarrays
11. An exploratory study examining how nano-liquid chromatography–mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease
12. The Use of Placenta-Derived Cells in Inflammatory and Fibrotic Disorders
13. Additional file 1 of Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells
14. THU-443 - NAFLD prevalence in the elderly declines with age and is associated with increased frailty, reduced physical function and social disadvantage status: results from the ASPREE study
15. Addressing the Liver Progenitor Cell Response and Hepatic Oxidative Stress in Experimental Non-alcoholic Fatty Liver Disease/non-alcoholic Steatohepatitis Using Amniotic Epithelial Cells
16. Long-term safety profile of cenicriviroc in adults with non-alcoholic steatohepatitis: rollover study
17. Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis
18. Additional file 1: of An exploratory study examining how nano-liquid chromatography–mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease
19. Phosphoproteomic Analysis Identifies Dynamic Regulation of Caveolin‐1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells
20. Pathway Analysis of Serum Analytes and Phosphorylated Proteins and their Involvement in Regulatory Pathways in Patients with Non-Alcoholic Steatohepatitis (NASH)
21. Association of Serum and Liver Proteomic Profiling of Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Reveals Common Pathways Linking Non-Alcoholic Steatohepatitis (NASH) and Metabolic Abnormalities
22. The Molecular Crosstalk Between Hepatic Tissue and Visceral Adipose Tissue in Patients with Obesity-Related Nonalcoholic Fatty Liver Disease (NAFLD): The Interactions between Inflammation and Immune Activation
23. The 6th International Conference on Self-Determination Theory: A review and emerging themes
24. MA04.06 Signaling Networks in KRAS-Mutant Advanced NSCLC: A Complex Landscape Involving Immunoresponse, Inflammation and DNA Repair
25. Mo1372 - The Molecular Crosstalk Between Hepatic Tissue and Visceral Adipose Tissue in Patients with Obesity-Related Nonalcoholic Fatty Liver Disease (NAFLD): The Interactions between Inflammation and Immune Activation
26. Sa1563 - Association of Serum and Liver Proteomic Profiling of Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Reveals Common Pathways Linking Non-Alcoholic Steatohepatitis (NASH) and Metabolic Abnormalities
27. 747 - Pathway Analysis of Serum Analytes and Phosphorylated Proteins and their Involvement in Regulatory Pathways in Patients with Non-Alcoholic Steatohepatitis (NASH)
28. THE ORIGIN OF ARCHIVAL TRAINING AT THE UNIVERSITY OF LIVERPOOL: THE SCHOOL OF LOCAL HISTORY AND RECORDS (1900–1948)
29. Chaotic dynamics in cardiac aggregates induced by potassium channel block
30. Pacemaker interactions induce reentrant wave dynamics in engineered cardiac culture
31. Stochastic and Spatial Influences on Drug-Induced Bifurcations in Cardiac Tissue Culture
32. Beyond insulin resistance in NASH: TNF-? or adiponectin?
33. FRI118 - Long-term safety profile of cenicriviroc in adults with non-alcoholic steatohepatitis: rollover study.
34. Beyond insulin resistance in NASH: TNF-α or adiponectin?
35. Pervasive Aniconism: A Cognitive Approach to Elagabal’s Sacred Stone of Emesa
36. An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease.
37. Abstinence debate. (Letters)
38. COVID-19 vaccinations in patients with chronic liver disease - experience of a tertiary centre in Melbourne.
39. FRI214 - Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis.
40. Reverse Phase Protein Microarrays.
41. Antibody Validation by Western Blotting.
42. Pacemaker interactions induce reentrant wave dynamics in engineered cardiac culture.
43. Chaotic dynamics in cardiac aggregates induced by potassium channel block.
44. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.